US Stock MarketDetailed Quotes

Novartis AG (NVS)

Watchlist
  • 148.160
  • +2.930+2.02%
Close May 12 16:00 ET
  • 148.840
  • +0.680+0.46%
Post 16:27 ET
282.70BMarket Cap21.23P/E (TTM)

Novartis AG (NVS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-0.70%13.52B
9.57%56.67B
2.23%13.86B
9.00%14.36B
15.26%14.84B
12.38%13.62B
10.85%51.72B
15.13%13.56B
8.93%13.17B
9.60%12.87B
Operating revenue
-0.91%13.11B
8.38%54.53B
1.39%13.34B
8.47%13.91B
12.32%14.05B
11.87%13.23B
10.73%50.32B
15.14%13.15B
8.84%12.82B
9.40%12.51B
Cost of revenue
7.19%3.46B
6.80%13.7B
8.63%3.61B
9.43%3.54B
4.70%3.32B
4.23%3.23B
2.85%12.83B
9.99%3.32B
3.75%3.23B
-5.06%3.17B
Gross profit
-3.16%10.07B
10.49%42.98B
0.15%10.25B
8.86%10.82B
18.71%11.51B
15.17%10.39B
13.77%38.9B
16.91%10.23B
10.73%9.94B
15.42%9.7B
Operating expense
1.75%5.83B
4.02%25.33B
-1.06%6.63B
0.11%6.32B
16.97%6.65B
1.40%5.73B
-0.28%24.35B
8.62%6.7B
-12.51%6.31B
1.59%5.69B
Selling and administrative expenses
2.68%3.14B
5.43%13.25B
-1.74%3.44B
5.55%3.31B
11.36%3.44B
7.68%3.06B
0.39%12.57B
1.66%3.5B
1.39%3.13B
0.00%3.09B
Research and development costs
15.81%2.74B
11.75%11.2B
11.29%3.16B
23.08%2.94B
15.21%2.73B
-2.27%2.37B
-11.86%10.02B
10.71%2.84B
-39.06%2.39B
2.73%2.37B
Other operating expenses
-116.34%-50M
-49.91%883M
-91.69%30M
-91.59%66M
111.89%481M
-21.54%306M
232.02%1.76B
124.22%361M
298.48%785M
12.94%227M
Operating profit
-9.18%4.24B
21.31%17.64B
2.44%3.62B
24.10%4.5B
21.18%4.86B
38.24%4.66B
48.88%14.54B
36.72%3.53B
105.85%3.63B
43.00%4.01B
Net non-operating interest income expense
-55.34%-393M
-42.86%-980M
-54.84%-96M
-26.47%-301M
-92.98%-330M
-17.67%-253M
-63.72%-686M
-513.33%-62M
-14.98%-238M
-30.53%-171M
Non-operating interest income
----
-34.33%373M
----
----
----
----
-9.41%568M
----
----
----
Non-operating interest expense
27.04%343M
13.72%1.14B
10.55%304M
6.44%281M
17.48%289M
22.17%270M
17.66%1.01B
26.73%275M
18.92%264M
13.89%246M
Total other finance cost
394.12%50M
-15.73%209M
-53.52%165M
176.92%20M
154.67%41M
-183.33%-17M
29.84%248M
-10.13%355M
-73.33%-26M
11.76%-75M
Other net income (expense)
0.00%-3M
-43.12%-312M
-65.03%-302M
0.00%-4M
-50.00%-3M
89.66%-3M
3.96%-218M
16.82%-183M
-33.33%-4M
0.00%-2M
Gain on sale of security
----
-66.67%-300M
----
----
----
----
15.89%-180M
----
----
----
Earnings from equity interest
0.00%-3M
68.42%-12M
33.33%-2M
0.00%-4M
-50.00%-3M
89.66%-3M
-192.31%-38M
50.00%-3M
-33.33%-4M
0.00%-2M
Income before tax
-12.89%3.84B
19.88%16.35B
-2.04%3.22B
23.96%4.2B
17.96%4.53B
40.84%4.41B
49.51%13.64B
38.20%3.29B
118.11%3.39B
43.64%3.84B
Income tax
-14.41%683M
40.21%2.39B
75.05%814M
33.00%266M
-14.79%507M
80.95%798M
208.71%1.7B
278.16%465M
412.82%200M
47.64%595M
Net income
-12.55%3.16B
16.99%13.97B
-14.75%2.4B
23.39%3.93B
23.97%4.02B
34.26%3.61B
-19.62%11.94B
-66.75%2.82B
80.66%3.19B
40.09%3.25B
Net income continuous Operations
-12.55%3.16B
16.99%13.97B
-14.75%2.4B
23.39%3.93B
23.97%4.02B
34.26%3.61B
39.28%11.94B
6.90%2.82B
110.51%3.19B
42.93%3.25B
Minority interest income
0
-750.00%-17M
-350.00%-5M
150.00%2M
-17M
3M
-150.00%-2M
2M
-300.00%-4M
0
Net income attributable to the parent company
-12.48%3.16B
17.11%13.98B
-14.51%2.41B
23.17%3.93B
24.49%4.04B
34.15%3.61B
-19.59%11.94B
-66.77%2.82B
81.09%3.19B
40.16%3.25B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.48%3.16B
17.11%13.98B
-14.51%2.41B
23.17%3.93B
24.49%4.04B
34.15%3.61B
-19.59%11.94B
-66.77%2.82B
81.09%3.19B
40.16%3.25B
Basic earnings per share
-9.84%1.65
21.79%7.21
-11.27%1.26
29.11%2.04
29.38%2.07
39.69%1.83
-17.20%5.92
-65.37%1.42
85.88%1.58
44.14%1.6
Diluted earnings per share
-9.34%1.65
21.81%7.15
-11.35%1.25
28.66%2.02
29.56%2.06
38.93%1.82
-17.32%5.87
-65.27%1.41
84.71%1.57
43.24%1.59
Dividend per share
18.68%4.7402
6.80%3.994
0
0
0
6.80%3.994
6.88%3.7395
0
0
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -0.70%13.52B9.57%56.67B2.23%13.86B9.00%14.36B15.26%14.84B12.38%13.62B10.85%51.72B15.13%13.56B8.93%13.17B9.60%12.87B
Operating revenue -0.91%13.11B8.38%54.53B1.39%13.34B8.47%13.91B12.32%14.05B11.87%13.23B10.73%50.32B15.14%13.15B8.84%12.82B9.40%12.51B
Cost of revenue 7.19%3.46B6.80%13.7B8.63%3.61B9.43%3.54B4.70%3.32B4.23%3.23B2.85%12.83B9.99%3.32B3.75%3.23B-5.06%3.17B
Gross profit -3.16%10.07B10.49%42.98B0.15%10.25B8.86%10.82B18.71%11.51B15.17%10.39B13.77%38.9B16.91%10.23B10.73%9.94B15.42%9.7B
Operating expense 1.75%5.83B4.02%25.33B-1.06%6.63B0.11%6.32B16.97%6.65B1.40%5.73B-0.28%24.35B8.62%6.7B-12.51%6.31B1.59%5.69B
Selling and administrative expenses 2.68%3.14B5.43%13.25B-1.74%3.44B5.55%3.31B11.36%3.44B7.68%3.06B0.39%12.57B1.66%3.5B1.39%3.13B0.00%3.09B
Research and development costs 15.81%2.74B11.75%11.2B11.29%3.16B23.08%2.94B15.21%2.73B-2.27%2.37B-11.86%10.02B10.71%2.84B-39.06%2.39B2.73%2.37B
Other operating expenses -116.34%-50M-49.91%883M-91.69%30M-91.59%66M111.89%481M-21.54%306M232.02%1.76B124.22%361M298.48%785M12.94%227M
Operating profit -9.18%4.24B21.31%17.64B2.44%3.62B24.10%4.5B21.18%4.86B38.24%4.66B48.88%14.54B36.72%3.53B105.85%3.63B43.00%4.01B
Net non-operating interest income expense -55.34%-393M-42.86%-980M-54.84%-96M-26.47%-301M-92.98%-330M-17.67%-253M-63.72%-686M-513.33%-62M-14.98%-238M-30.53%-171M
Non-operating interest income -----34.33%373M-----------------9.41%568M------------
Non-operating interest expense 27.04%343M13.72%1.14B10.55%304M6.44%281M17.48%289M22.17%270M17.66%1.01B26.73%275M18.92%264M13.89%246M
Total other finance cost 394.12%50M-15.73%209M-53.52%165M176.92%20M154.67%41M-183.33%-17M29.84%248M-10.13%355M-73.33%-26M11.76%-75M
Other net income (expense) 0.00%-3M-43.12%-312M-65.03%-302M0.00%-4M-50.00%-3M89.66%-3M3.96%-218M16.82%-183M-33.33%-4M0.00%-2M
Gain on sale of security -----66.67%-300M----------------15.89%-180M------------
Earnings from equity interest 0.00%-3M68.42%-12M33.33%-2M0.00%-4M-50.00%-3M89.66%-3M-192.31%-38M50.00%-3M-33.33%-4M0.00%-2M
Income before tax -12.89%3.84B19.88%16.35B-2.04%3.22B23.96%4.2B17.96%4.53B40.84%4.41B49.51%13.64B38.20%3.29B118.11%3.39B43.64%3.84B
Income tax -14.41%683M40.21%2.39B75.05%814M33.00%266M-14.79%507M80.95%798M208.71%1.7B278.16%465M412.82%200M47.64%595M
Net income -12.55%3.16B16.99%13.97B-14.75%2.4B23.39%3.93B23.97%4.02B34.26%3.61B-19.62%11.94B-66.75%2.82B80.66%3.19B40.09%3.25B
Net income continuous Operations -12.55%3.16B16.99%13.97B-14.75%2.4B23.39%3.93B23.97%4.02B34.26%3.61B39.28%11.94B6.90%2.82B110.51%3.19B42.93%3.25B
Minority interest income 0-750.00%-17M-350.00%-5M150.00%2M-17M3M-150.00%-2M2M-300.00%-4M0
Net income attributable to the parent company -12.48%3.16B17.11%13.98B-14.51%2.41B23.17%3.93B24.49%4.04B34.15%3.61B-19.59%11.94B-66.77%2.82B81.09%3.19B40.16%3.25B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.48%3.16B17.11%13.98B-14.51%2.41B23.17%3.93B24.49%4.04B34.15%3.61B-19.59%11.94B-66.77%2.82B81.09%3.19B40.16%3.25B
Basic earnings per share -9.84%1.6521.79%7.21-11.27%1.2629.11%2.0429.38%2.0739.69%1.83-17.20%5.92-65.37%1.4285.88%1.5844.14%1.6
Diluted earnings per share -9.34%1.6521.81%7.15-11.35%1.2528.66%2.0229.56%2.0638.93%1.82-17.32%5.87-65.27%1.4184.71%1.5743.24%1.59
Dividend per share 18.68%4.74026.80%3.9940006.80%3.9946.88%3.7395000
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More